aminoimidazole carboxamide has been researched along with olanzapine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diéguez, C; Fernø, J; López, M; Nogueiras, R; Skrede, S; Steen, VM; Varela, L; Vázquez, MJ; Vidal-Puig, A | 1 |
| Bush, ND; Townsend, LK; Wright, DC | 1 |
2 other study(ies) available for aminoimidazole carboxamide and olanzapine
| Article | Year |
|---|---|
Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylation.
Topics: Agouti-Related Protein; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Arcuate Nucleus of Hypothalamus; Benzodiazepines; Clozapine; Feeding Behavior; Female; Gene Expression Regulation; Hyperphagia; Hypothalamus; Injections, Intraventricular; Insulin; Intracellular Signaling Peptides and Proteins; Leptin; Neuropeptide Y; Neuropeptides; Olanzapine; Orexins; Phosphorylation; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Weight Gain | 2011 |
AICAR Prevents Acute Olanzapine-Induced Disturbances in Glucose Homeostasis.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blood Glucose; Glucose; Homeostasis; Hyperglycemia; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Olanzapine; Pyruvic Acid; Ribonucleosides; Signal Transduction | 2018 |